Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease.
- DOI
- 10.1016/j.bbi.2025.04.037
- Published
- 2025 Aug
- Container
- Brain, behavior, and immunity
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bbi.2025.04.037,
title = {Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease.},
author = {Ayerra L and Abellanas MA and Vidaurre C and Basurco L and Tavira A and Luquin E and Clavero P and Mengual E and Collantes M and Peñuelas I and de Martin-Esteban SR and Grether U and Hillard CJ and Romero J and Hervás-Stubbs S and Aymerich MS},
year = {2025},
journal = {Brain, behavior, and immunity},
doi = {10.1016/j.bbi.2025.04.037},
url = {https://doi.org/10.1016/j.bbi.2025.04.037}
}RIS
TY - JOUR TI - Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease. AU - Ayerra L AU - Abellanas MA AU - Vidaurre C AU - Basurco L AU - Tavira A AU - Luquin E AU - Clavero P AU - Mengual E AU - Collantes M AU - Peñuelas I AU - de Martin-Esteban SR AU - Grether U AU - Hillard CJ AU - Romero J AU - Hervás-Stubbs S AU - Aymerich MS PY - 2025 JO - Brain, behavior, and immunity DO - 10.1016/j.bbi.2025.04.037 UR - https://doi.org/10.1016/j.bbi.2025.04.037 ER -
APA
L, A., MA, A., C, V., L, B., A, T., E, L., P, C., E, M., M, C., I, P., SR, D. M., U, G., CJ, H., J, R., S, H., & MS, A. (2025). Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease.. Brain, behavior, and immunity. https://doi.org/10.1016/j.bbi.2025.04.037
Source records
- pubmed · retrieved 2026-09-25T06:10:12.584Z